Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
14 April 2020updated 06 Oct 2020 9:45am

AstraZeneca to trial blood cancer drug as Covid-19 treatment

By Samuel Horti

Pharmaceutical company AstraZeneca has launched a global trial to test the effectiveness of Calquence, currently used to treat lyphoma and leukemia, in Covid-19 patients.

The company will trial whether Calquence, a brand name of the drug acalabrutinib, could treat the hyperactive immune response associated with severe Covid-19. AstraZeneca’s executive vice president of research & development oncology José Baselga said the company hopes to demonstrate “that adding Calquence to best supportive care reduces the need to place patients on ventilators and improves their chances of survival”.

Read the full story at Pharmaceutical Technology

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s weekly environment email on the politics, business and culture of the climate and nature crises - in your inbox every Thursday. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A newsletter showcasing the finest writing from the ideas section and the NS archive, covering political ideas, philosophy, criticism and intellectual history - sent every Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.

Content from our partners
How do we secure the hybrid office?
How materials innovation can help achieve net zero and level-up the UK
Fantastic mental well-being strategies and where to find them